Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Feb 15, 2024 9:02am
182 Views
Post# 35881515

RE:90 REACHED!!

RE:90 REACHED!!

Congrats to Spectral for picking up the pace and achieving this important milestone ! 


...and for making a mockery of Hmmmmm's prediction last February. 

"You would think this would be a 3 alarm fire for Spectral's management- at this rate it will take almost 7 years to reach the 150 patients required."- Hmmmm Feb 2023

I wonder if he'll apologize for those comments, the bad math, and for discouraging " his fellow investors" from realizing  up to 100-150% on new investments made around that time period ?


Clearly at the recent pace of 7 per month, and likely ramping up to perhaps 9 per month with new sites, the 150 could be easily be achieved  in another 7-9 months assuming that the recent pace is maintained.

And new investors are often attracted,at an accelerated rate, to Companies that are approaching Trial end points ... kinda like happened in 2016. 

MM

 

<< Previous
Bullboard Posts
Next >>